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Background: Children with overweight/obesity and congenital heart disease (CHD) are
at increased cardiovascular risk. A lifestyle intervention may help reduce these risks.
We sought to determine the feasibility of a smartphone-based lifestyle intervention to
improve cardiovascular health outcomes in children with overweight/obesity and CHD.
Methods: We examined the effect of bi-weekly nutrition and fitness counseling delivered
via smartphone over 12 months. Thirty-four youth, previously diagnosed with CHD and
with overweight or obesity, participated in the intervention. They were divided into two
groups depending on whether the heart disease required surgical correction (operated,
n = 19) or not (non-operated, n = 15). Anthropometry, body composition cardiorespiratory exercise capacity, and cardio-metabolic risk factors were assessed at baseline,
6 months, and 12 months.
results: Statistically significant decreases in waist circumference (WC), body mass
index z-score, WC z-score, and waist to height ratio z-score were observed at 6 and
12 months in the operated group. A significant linear increase in lean body mass was
observed in both groups. The study also had a high retention rate and a low attrition rate.
conclusion: The observed changes in anthropometry were positive with significant
improvement to some cardiovascular and metabolic risk indicators. However, this was
only observed in the operated group suggesting that other factors, such as perception
of condition and self-efficacy, may influence lifestyle behaviors. The results from this pilot
study clearly demonstrate the feasibility to perform a larger controlled study on remote
lifestyle intervention in children with congenital heart defects and overweight or obesity.
Keywords: smartphone, congenital heart disease, remote counseling, obesity, children, lifestyle intervention
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INTRODUCTION

MATERIALS AND METHODS

Currently, about one-third of children in Canada and the United
States are overweight or obese, and our group and others have
found that the prevalence of overweight and obesity between
children with congenital heart disease (CHD) and healthy children do not differ significantly (1–3). The numerous cardiovascular risks, and physical and psychosocial health consequences
of childhood obesity are well reviewed (4, 5). Although evidence
is now emerging, children with overweight or obesity and CHD
appear more likely to exhibit additional cardiovascular risk
factors, such as higher systolic blood pressure and lower high
density lipoproteins (HDL), compared to children of normal
weight (1, 6).
Unhealthy eating habits, sedentary behavior, and reduced
physical activity can increase the risk of obesity and cardiovascular disease (7). Children with CHD are less physically active
(8) and have a lower health-related quality of life than their peers
(9). Although a structured lifestyle intervention for children
and youth with overweight or obesity and CHD has never been
completed, it has the potential to diminish cardiovascular health
risks by improving nutrition, physical fitness, body composition, and related health outcomes (10). However, conventional
pediatric lifestyle intervention programs struggle with barriers
to their success, such as high attrition rates and therapeutic noncompliance (11).
Smartphones may address some of the inherent challenges
of structured lifestyle interventions by eliminating geographical barriers, maintaining the home environment and appealing
to a more technologically savvy generation. Overall, mobile
devices offer promising results for improving weight loss and
health behaviors, but their application has not been explored
in a pediatric population with overweight or obesity and
CHD (12–14). In addition, weight-loss interventions using
remote counseling have been shown to be as effective as inperson support for weight loss in an adult population with
obesity (15).
The objective of the “Smart Heart” Pilot Study (registered as
NCT02980393 at http://www.ClinicalTrials.gov) was to examine
the cardiovascular health impact of a 12-month, structured
lifestyle intervention program for children and adolescents with
overweight or obesity and CHD through the use of smartphones.
It was hypothesized that participants would demonstrate favorable changes in anthropometric, body composition, exercise
capacity, and metabolic parameters associated with cardiovascular health. We also sought to determine if self-efficacy resulting
from the perceived severity of CHD influences the outcomes of
the intervention.

Study Design

Eligible candidates were selected during routine visits and through
chart review by cardiologists at the London Health Sciences
Centre (LHSC) (London, ON, Canada). Consenting individuals
underwent a physical assessment and a review of medications and
comorbidities during the first stage of measurements. All patients
were recruited from within our catchment area of Southwestern
Ontario, Canada.
Two groups of patients were recruited for this study, those
who had undergone corrective surgery for CHD (“operated”) and
those with minor heart defects that do not require surgical correction (“non-operated”). All subjects had overweight or obesity.
Both groups received the identical intervention.
Candidates were excluded from the study if they: had severe
residual heart disease, were at risk for a worsening cardiac
condition, were unable to participate due to mental or physical disabilities, had imposed exercise restrictions, were taking
confounding medications, had comorbidities affecting weight or
metabolic conditions, or were involved in any concurrent lifestyle
intervention. This study was approved by the Western University
Health Science Research Ethics Board (REB#18843) and the
Lawson Health Research Institute (R-12-266). All subjects gave
written informed consent in accordance with the Declaration
of Helsinki. All children and adolescents gave written informed
consent to participate in this study. For those under 16 years of
age, we obtained written informed consent from their parents/
guardians.
The primary outcome measures were anthropometry, body
composition, and cardiorespiratory exercise capacity. The
secondary metrics included biochemical markers associated
with cardiovascular health and risk. Outcomes were assessed at
baseline and 6 and 12 months following baseline at the Children’s
Hospital, LHSC and Western University, Ontario, Canada. The
Smart Heart Pilot Study protocol is outlined in Figure 1.

Primary Outcome Measures
Anthropometry

Weight and height were measured to the nearest 0.1 kg and to
the nearest 0.1 cm, respectively. Waist circumference (WC) was
measured according to the NHANES III Body Measurements
protocol (16). Briefly, WC was measured at least twice with a
flexible tape to the nearest 0.1 cm at the tip of the iliac crest. An
average was taken of the first two measures with internal variation of ≤1 cm. The z-scores were calculated using the following
  X L 
    −1
 M  
 , where X is the BMI, WC, or waist to
formula: z = 
LS
height ratio (WHtR); L is lambda, M is mu, and S is sigma. Age
and gender based values for L, M, and S were obtained from the
growth charts provided by the CDC and Sharma et al. (17, 18).

Abbreviations: CHD, congenital heart disease; iDXA, dual X-ray absorptiometry;
BMI, body mass index; BMI-Z, body mass index z-score; WC, waist circumference;
WC-Z, waist circumference z-score; WHtR, waist to height ratio; WHtR-Z, waist to
height ratio z-score; FM, fat mass; BF, body fat; %BF, percent body fat; LBM, lean
body mass; VO2max, maximal volume oxygen uptake; LDL, low density lipoproteins;
HDL, high density lipoproteins; TG, triglycerides; HOMA-IR, homeostatic model
assessment for insulin resistance.
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Body Composition Measurements

Dual X-ray absorptiometry (iDXA; General Electric-Lunar
iDXA, Ames Medical iDXA; Prodigy, enCORE 2007 software
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Figure 1 | Flow diagram of the Smart Heart Pilot Study procedure from baseline to 12-month measures. The Smart Heart Pilot Study included three assessments
and spanned 12 months. Self-report, physical, metabolic, cardiovascular, and body composition outcome measures were collected for each participant at baseline
and at 6- and 12-month follow-ups. Nutrition and fitness counseling was performed by smartphone once per week, with the nutrition and fitness counseling support
alternating weeks (i.e., 25 counseling sessions for each, for a total of 50 sessions).

version 11.40.004, Waukesha, WI, USA) was used to measure
body fat (kg) and lean body mass (LBM) (kg). Lunar iDXA has
been previously validated (19).

alternating weekly phone calls with two health coaches: a
registered dietitian and a fitness specialist. A total of 50 phone
calls were delivered to each participant over the 12 months.
Counseling sessions were ≤30 min. Counseling strategies were
focused on education, behaviors, and family engagement and
included regular evaluations. The primary counseling topics are
outlined in Table 1. The counseling was tailored to the specific
needs of each patient (e.g., lactose intolerance, sports nutrition,
exercise modifications during injury recovery), and good sleeping habits were emphasized.

Cardiorespiratory Exercise Capacity

Tests were performed at the Pediatric Cardiopulmonary Research
Laboratory, Children’s Hospital, LHSC, or at the Exercise and
Health Psychology Lab, Western University, Ontario, Canada.
Breath-by-breath data on the volume of oxygen uptake (VO2)
(mL) and carbon dioxide production (mL) were collected during
a maximal exercise graded treadmill test using a Cosmed Quark
b2 indirect calorimetry metabolic system (Cosmed S.r.I, Rome,
Italy). An electrocardiogram was used simultaneously to monitor
heart rate and identify arrhythmias and ST changes. The goal was
to determine peak VO2 based on a respiratory exchange ratio (R)
≥1.05 (20).

Statistical Analyses

Means and SDs were calculated for all continuous variables. With
the exception of z-scores, RM-ANCOVA was conducted for
each outcome across the three time points (baseline, 6 months,
and 12 months), while adjusting for age and sex. The z-scores
(already adjusted for age and sex) for BMI (BMI-Z), WC (WCZ), and WHtR (WHtR-Z) were analyzed using RM-ANOVA. The
analyses were performed independently on both the operated
and non-operated groups. For outcomes significant at p < 0.05,
Bonferroni post hoc comparisons examined pairwise differences
between time points.
BMI z-scores were also calculated from clinic visits from 6 to
42 months prior to the start of the study (Figure 2). This time
frame was selected as it represented a long enough period prior
to study start to observe any trends and maximized the availability of data for performing linear regression. A smoothed
line of fit was determined for each group using locally weighted
scatterplot smoothing (loess) and 70% of the data points with the
Epanechnikov kernel. Linear regression was used to determine the
pre-intervention body mass index z-score (BMI-Z) trajectory for
each group using data up to, and including, the baseline.

Secondary Outcome Measures

Participants fasted for ≥10 h and blood collected. The lipid
profile [total cholesterol, triglycerides and high and low density
lipoproteins (HDL, LDL)], fasting plasma glucose, hemoglobin
A1C, and insulin levels were measured using standard protocols at the LHSC Core laboratory. The homeostatic model
assessment—insulin resistance [homeostatic model assessment
for insulin resistance (HOMA-IR)] was calculated using the folFPG ∗ ( FPI ∗ 0.144 )
; where FPG is
lowing formula: HOMA IR =
22.5
fasting plasma glucose levels (mmol/L) and FPI is fasting plasma
insulin levels (pmol/L).

Lifestyle Intervention

During the baseline visit, participants were provided a complimentary smartphone. The lifestyle intervention involved
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innominate vein, mitral valve prolapse, mitral valve regurgitation, patent ductus arteriosus, pulmonic stenosis, subaortic ridge,
systolic ejection murmur, or ventricular septal defect.
The fitness and nutrition counselors allocated 30 min for each
session: 15–20 min for counseling and 10–15 min for charting.
Thus, the primary cost of applying the intervention was approximately a combined 25 professional working hours for the weekly
remote smartphone counseling per participant over 12 months.
There was no significant difference between HDL, LDL,
TG, fasting plasma glucose, hemoglobin A1C, insulin levels,
HOMA-IR, and maximal volume oxygen uptake at baseline,
6 months, or 12 months for both groups.
Tables 2 and 3 summarize the key outcome measures at
baseline, 6 months, and 12 months. There was a significant
linear decrease in WC, BMI-Z, waist circumference z-score
(WC-Z), and WHtR-Z over 12 months in the operated group.
Post hoc comparisons showed significant differences between
baseline and both the 6- and 12-month time points for BMI-Z,
WC-Z, WHtR-Z, and LBM. There was only a significant difference between baseline and the 6-month time point for WC. By
the end of the study, BMI-Z decreased by 0.12 (95% CI 0.002
to 0.28), WC-Z decreased by 0.24 (95% CI 0.05 to 0.43), and
WHtR-Z decreased by 0.26 (95% CI 0.02 to 0.50). WC decreased
by 2.61 cm (0.12 to 5.09) after 6 months, and by 2.25 cm (−1.58
to 6.09) after 12 months, but the decrease at study end was not
significant relative to baseline (Table 2). For the non-operated
group a small, but significant, increase in the BMI of 1.50 (95%
CI −0.13 to 2.87) between baseline and 12 months was observed
(Table 3). A significant linear increase in LBM over the 12-month
period, with an increase of 2.87 kg (95% CI 1.47 to 4.26) and
2.32 kg (95% CI 0.40 to 4.23) at study end, was observed for both
the operated and non-operated groups, respectively.
Examining the trend in BMI-Z prior to the start of the study
until study completion revealed interesting trends (Figure 2). For
the operated group (solid black line), the BMI-Z increased over
time until the start of the intervention at which the BMI-Z showed
a decline until the study end. However, for the non-operated
group (solid gray line), the BMI-Z showed a similar increase
over time prior to the start of the intervention, but leveled off
after, and reverted back to an increasing trajectory. Of note, the
BMI-Z was approximately 0.5 higher throughout in the operated
group relative to the non-operated group. This is attributed to
the group composition, as 74% of the operated, and 27% of the
non-operated, group had obesity. A pre-intervention trajectory
was determined for each group using linear regression on data
spanning 42 months prior to, and including, baseline (dashed
lines). Comparing the overall line of fit to the trajectories one can
readily observe the impact of the intervention. The decrease in
BMI-Z in the operated group is apparent, but also of note is the
disruption to an expected increase in BMI-Z in the non-operated
group (Figure 2).

Table 1 | Lifestyle counseling: the primary topics for nutrition and fitness.
Nutrition program counseling topics

Fitness program counseling topics

Education and strategies
• Canada’s Food Guide as a resource
• Planning balanced and healthier meals
• Approaches to grocery shopping
• Understanding nutrition labels
• Choosing healthier drinks over sugarsweetened drinks
• Increasing consumption of vegetables
and fruit
• Strategies for eating outside of home
• Packing lunches
• Family meals
• Eating breakfast

Education and strategies
• Canada’s Physical Activity and
Sedentary Behavior Guidelines as
a resource
• Benefits of physical activity and
impacts of sedentary behavior
• Interconnection of lifestyle behaviors
(sleep, activity)
• Supports and environments (home,
school, etc.)
• Intensity levels

Behaviors
• Eating in moderation
• Slower eating
• Focused eating
• Division of responsibility in feeding
• Snacking
• Hunger and satiety cues
• Emotional eating

Behaviors
Phase 1. Months 0–6
• Planning and goal-setting
• Self-monitoring
• Overcoming barriers
• Incorporating activity into regular
daily routine (e.g., taking the stairs)

Phase 1. Months 0–6: Bi-weekly
resources

Phase 2. Months 6–12
• Challenging current physical activity
levels and diversity of movement
choices
• Sustaining motivation levels and
incorporation of rewards

Phase 2. Months 6–12: Monthly
nutrition challenges

Evaluation:
Bi-weekly (physical activity recall)

Family engagement

Evaluation
Every 3 months (food records or diet
recall)
Eating habits questionnaires (4 in total)
(phase 2. Months 6–12 only)

All statistical analyses were performed using SPSS v.23 or v.24
(IBM Corporation, Armonk, NY, USA).

RESULTS
Patient recruitment spanned May 2012 to October 2015. Thirtyfour patients (15 females, 19 males) with overweight or obesity
(21), between 7 and 17 years of age (mean 14.3 ± 2.8 years) at
the time of screening, were recruited. Of these, n = 19 had CHD
that required corrective surgery (operated group) while n = 15
had CHD that did not require corrective surgery (non-operated
group). Patient assessments spanned January 2013 to October
2016. One participant from each group did not complete the
6-month follow-up assessment and were excluded from all
repeated measures statistical analyses.
The operated group consisted of patients diagnosed with
one or more of the following: aortic stenosis, atrial septal defect
(type II), atrio-ventricular septal defect, coarctation of the aorta,
hemitruncus, hypoplastic left heart syndrome, patent ductus
arteriosus, pulmonic stenosis, transposition of the great arteries,
or tetralogy of Fallot. While the non-operated group consisted
of patients diagnosed with one or more of the following: aortic
root dilation, aortic stenosis, aortic valve regurgitation, ascending aortic dilatation, atrial septal defect (type II), bicuspid
aortic valve, coronary sinus atresia, coronary sinus draining into
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DISCUSSION
Our pilot and feasibility study on a smartphone-based lifestyle
intervention successfully demonstrated improved anthropome
tric and body composition measures in children with overweight
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Figure 2 | Trends in body mass index z-score (BMI-Z) score. The BMI-Z was plotted over time (months) relative to the study start date (month 0) for each of the 34
participants divided into the operated congenital heart disease (CHD) (n = 19) and non-operated CHD (n = 15) groups. The BMI-Z was determined for each of the
34 study participants, when possible, from 42 months to 6 months prior to the study start date (month 0) and during the intervention at 0, 6, and 12 months. Loess
was used to generate a smoothed line of fit for the operated (solid black line) and non-operated (solid gray line) groups. Linear regression was performed using data
from months −42 to 0 to determine a trajectory for the BMI-Z (dashed lines). For the operated group, n = 14 of 19 had from 2 to 4 BMI-Z measurements prior to the
study start; while for the non-operated group, n = 11 of 15 had 1 to 3 BMI-Z measurements prior to the study start. All 34 participants had BMI-Z measurements
over the course of the intervention (i.e., at 0, 6, and 12 months) with the exception of one participant in each of the two groups that missed the 6-month follow-up.
The study start point (0 months) is indicated by a vertical line.

or obesity and operated CHD. While we did not observe the same
outcomes in the non-operated group, we did observe a disruption
in the predicted linear increase in BMI-Z likely attributed to the
intervention. To the best of our knowledge, this is the first study to
implement this type of intervention in a pediatric CHD population. Furthermore, our study had superior participant retention
and attrition rates compared to similar lifestyle intervention
studies (22). We believe this to be attributed to the use of smartphones in the study, which enabled us to effectively engage with
the participants, despite geographic or scheduling limitations.
Overall, the results from this study effectively demonstrated the
feasibility of the current protocol, and the implemented remote
lifestyle intervention strategy, to move forward with a larger
controlled study.
In a systematic review of 38 eligible studies conducted
between 1975 and 2010, Ho et al. concluded that pooled pediatric obesity lifestyle interventions reduced BMI-Z by 0.10 (95%
CI 0.02–0.18) (22). A similar change was seen in the operated
study group, suggesting the intervention was as successful as

Frontiers in Pediatrics | www.frontiersin.org

other interventions at decreasing and sustaining BMI-Z for the
6- and 12-month periods. Few lifestyle intervention studies on
children and adolescents with overweight or obesity employed
WC, WHtR, or their corresponding z-scores as part of their
outcome measures; for studies that did so, the results were
inconsistent (22).
For the operated group, changes in BMI-Z, WC, WC-Z, and
WHtR-Z occurred within the first 6 months of the program
and remained relatively unchanged at 12 months. This was not
unexpected, as Franz et al. reported that the largest loss in weight
occurred within the first 6 months and was maintained after
12 months in a review of 80 weight-loss intervention studies in
adults (23). Moreover, Franz et al. stated that although weight
loss leveled off after the initial reduction, stopping the interventions altogether would likely have led to weight gain (23). Since
there were no increases in anthropometric measures after the
6-month point in our study, this suggests that participants in the
operated group were likely still engaged with the intervention
while the non-operated group was not. This also indicates that
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Table 2 | Comparison of anthropometric, body composition, cardiorespiratory and cardio-metabolic risk factor outcome measures for the operated group.
Measurements

Heart rateb (bpm)
Systolic BPa (mmHg)
Diastolic BPa (mmHg)
BMI (kg/m2)
BMI-Z
WCa (cm)
WC-Za
WHtR
WHtR-Z
Fat mass (kg)
Body fat (%)
Lean body mass (kg)
Lean body mass (%)

Baseline,
mean (SD)

6 months,
mean (SD)

12 months,
mean (SD)

p-Value

97.7 (10.1)
114.0 (11.7)
62.9 (8.4)
30.17 (4.95)
2.06 (0.374)
95.91 (11.75)
1.72 (0.393)
0.584 (0.076)
1.50 (0.574)
33.28 (10.22)
41.08 (7.30)
47.97 (13.92)
57.13 (6.71)

89.2 (16.9)
114.8 (6.8)
68.3 (2.3)
29.71 (4.47)
1.95 (0.398)
93.30 (11.77)
1.53 (0.546)
0.562 (0.084)
1.27 (0.719)
32.02 (9.53)
38.64 (8.09)
49.23 (14.18)
58.44 (7.80)

98.2 (12.6)
116.4 (8.7)
69.9 (5.4)
29.79 (4.31)
1.92 (0.395)
93.65 (10.63)
1.48 (0.551)
0.566 (0.096)
1.24 (0.718)
32.27 (9.53)
38.24 (8.04)
50.84 (13.94)
59.01 (7.65)

0.873
0.225
0.404
0.207
0.012*
0.028*
0.001*
0.994
0.003*
0.177
0.297
0.009*
0.731

Mean difference B
to 6 (95% CI)
−8.4 (−19.2 to 2.4)
0.8 (−5.4 to 7.0)
5.3 (−1.0 to 11.6)
−0.47 (−1.50 to 0.57)
−0.10 (−0.21 to −0.002)*
−2.61 (−5.09 to −0.12)*
−0.19 (−0.33 to −0.06)*
−0.022 (−0.039 to 0.004)
−0.23 (−0.38 to −0.08)*
−1.26 (−3.25 to 0.73)
−2.44 (−5.86 to 0.97)
1.26 (0.06 to 2.47)*
1.31 (−0.81 to 2.69)

Mean difference B
to 12 (95% CI)
0.5 (7.7 to 8.7)
2.4 (−5.0 to 9.8)
7.0 (−0.2 to 14.2)
−0.38 (−1.79 to 1.02)
−0.14 (−0.28 to −0.002)*
−2.25 (−6.09 to 1.58)
−0.24 (−0.43 to −0.05)*
−0.024 (−0.049 to 0.002)
−0.26 (−0.50 to −0.02)*
−1.01 (−4.34 to 2.32)
−2.84 (−6.20 to 0.51)
2.87 (1.47 to 4.26)**
1.88 (0.30 to 4.06)

p-value from RM-ANOVA or RM-ANCOVA.
95% CI, 95% confidence interval for mean difference between baseline (B) and 6 months (6) or 12 months (12); BP, blood pressure; BMI, body mass index; WC, waist
circumference; WHtR, waist to height ratio; -Z, z-score.
n = 18, unless otherwise indicated.
a
n = 16.
b
n = 17.
*Post hoc test p ≤ 0.05.
**Post hoc test p ≤ 0.001.

Table 3 | Comparison of anthropometric, body composition, cardiorespiratory and cardio-metabolic risk factor outcome measures for the non-operated group.
Measurements

Baseline,
mean (SD)

6 months,
mean (SD)

12 months,
mean (SD)

p-Value

Heart Ratec (bpm)
Systolic BPa (mmHg)
Diastolic BPa (mmHg)
BMI (kg/m2)
BMI-Z
WCb (cm)
WC-Zb
WHtRb
WHtR-Zb
Fat Mass (kg)
Body Fat (%)
Lean Body Mass (kg)
Lean Body Mass (%)

102.7 (10.5)
119.5 (8.2)
72.9 (8.4)
27.74 (4.42)
1.63 (0.49)
98.0 (13.5)
1.56 (0.49)
0.60 (0.07)
1.47 (0.52)
29.8 (9.5)
39.5 (5.5)
44.3 (86)
59.3 (5.35)

96.8 (12.4)
119.6 (10.3)
70.1 (6.3)
27.95 (4.24)
1.61 (0.52)
99.5 (8.5)
1.62 (0.34)
0.60 (0.05)
1.55 (0.33)
30.1 (9.1)
39.2 (5.7)
45.0 (84)
58.8 (5.78)

102.2 (14.4)
122.2 (9.9)
69.5 (6.6)
29.24 (4.81)
1.70 (0.55)
103.2 (11.8)
1.67 (0.41)
0.62 (0.07)
1.62 (0.44)
32.7 (11.3)
40.3 (6.5)
46.6 (8.5)
57.8 (6.34)

0.910
0.412
0.335
0.046*
0.182
0.760
0.312
0.892
0.287
0.076
0.579
0.000*
0.220

Mean difference
B to 6 (95% CI)
−5.91 (−16.4 to 4.6)
0.08 (−8.6 to 8.8)
−2.8 (−11.7 to 6.2)
0.20 (−0.65 to 1.06)
−0.026 (−0.16 to 0.11)
1.6 (−3.7 to 6.8)
0.07 (−0.14 to 0.26)
0.003 (−0.025 to 0.032)
0.08 (−0.15 to 0.31)
0.23 (−2.93 to 3.39)
−0.29 (−2.7 to 21)
0.73 (−1.12 to 2.59)
−0.51 (−2.41 to 1.39)

Mean difference
B to 12 (95% CI)
−0.55 (−7.7 to 6.6)
2.7 (−5.9 to 11.3)
−3.3 (−11.7 to 5.1)
1.50 (−0.13 to 2.87)*
0.07 (−0.10 to 0.24)
5.3 (−0.3 to 10.3)
0.12 (−0.14 to 0.37)
0.022 (−0.012 to 0.055)
0.15 (−0.18 to 0.48)
2.93 (−1.46 to 7.13)
0.76 (−2.26 to 379)
2.32 (0.40 to 4.23)*
−1.48 (−4.03 to 1.07)

p-value from RM-ANOVA or RM-ANCOVA.
95% CI, 95% confidence interval for mean difference between baseline (B) and 6 months (6) or 12 months (12); BP, blood pressure; BMI, body mass index; WC, waist
circumference; WHtR, waist to height ratio; -Z, z-score.
n = 14, unless otherwise indicated.
a
n = 13.
b
n = 12.
c
n = 11.
*Post hoc test p ≤ 0.05.

the intervention may not have been rigorous enough, and positive changes may have continued with a more aggressive diet and
exercise plan.
The significant findings in the operated group were not
entirely replicated in the non-operated group, although they both
received the identical intervention. We believe this may be due
self-efficacy and how the parents/patients perceive the seriousness
of their condition in relation to lifestyle (24–26). For example,
the operated group may have had a much better understanding
of their disease and the impact of overweight and obesity on their
health and were more engaged as a result. It is also possible the
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operated group had been more reserved in their physical activity
due to the perceived seriousness of their condition and increased
efforts during the intervention as it was regularly monitored by
medical professionals. However, it is important to note that most
of the participants in the operated group were obese, whereas
the non-operated participants were predominantly overweight,
which may have enabled more rapid positive changes from the
intervention. We believe further studies are warranted to test
these hypotheses.
A meta-analysis by Stoner et al. found that structured exercise
interventions slightly increased LBM by 1.6 kg (95% CI 0.5–2.6)
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while also attenuating percent body fat (%BF) by 3.1% (95% CI
2.2–4.1) in overweight and obese adolescents (27). While we
observed a significant linear increase in age and sex adjusted
LBM by 2.9 kg (95% CI 1.47–4.26) from baseline, there was
no apparent increase in the percent LBM. This suggests that
LBM and total body mass increased linearly together over the
12-month period. However, there appeared to be decreases in
the fat mass and %BF from baseline to 6 and 12 months in our
study, but it did not reach statistical significance due to the large
variance (Table 2). Thus, the increased LBM is likely the result
of normal childhood growth. This is not surprising given that
our intervention did not include a regimented physical exercise
component and structured resistance or weight training components. Also, another possibility was the sample size in our study
was not representative enough to adjust for the strong association
between LBM and pubertal growth.
We did not observe any significant changes in any of the
measured cardio-metabolic outcomes in our study as reported
with other interventions (22). However, as reported in a review
by Ho et al., there were no clear associations between the extent
of weight loss or body fat reduction and improvements in cardiometabolic outcomes (22). Thus, the changes observed in these
studies may independently result from the lifestyle intervention
itself, through increased physical activity and an improved diet,
as opposed to weight loss directly. While we did observe positive
anthropometric changes in our study, the intervention may not
have been adequate enough to drive improvements in cardiometabolic outcomes.
A significant increase in peak VO2 has been reported in several
studies on physical exercise training programs in children and
young adults with CHD (28, 29). Similar age and sex adjusted
results were not observed in our study, which was likely a consequence of lacking a regimented physical exercise component and
participant engagement.
The differences observed between this study and those
reported in the reviews by Ho et al. (22), Tikkanen et al. (28),
and Duppen et al. (29) may be explained by limitations of the
intervention components. For instance, Ho et al. (22) noted the
features of effective interventions were: family involvement,
dietary intervention (typically a structured restrictive diet),
and structured exercise training (22). Unfortunately, the Smart
Heart Pilot Study did not strive for significant family involvement, which may have had an impact on the study, as engaging family members can enhance the effectiveness of weight
management (30, 31). Also, dietary and fitness components
were designed to be realistic, sustainable, and empowering for
young people living in an uncontrolled environment; as such
we did not prescribe regimented diet and exercise plans. Since
the physical activity component of lifestyle interventions is
specifically associated with improvements in body composition,
one must also consider the differing degrees of physical activity participation (frequency, duration, and intensity) achieved
by study participants as a potential explanation. Furthermore,
reliance on participant self-report regarding their engagement
in physical activity was an additional challenge to increasing
physical activity levels in this remote intervention as self-report
can be influenced by social desirability and recall bias, and may
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also lead to overestimations of both the quantity and intensity
of effort (32).
Ultimately, one of the primary reasons we did not observe
significant differences in many of the cardio-metabolic and body
composition outcome measures was likely a consequence of
the small sample size used in the study. We were hopeful the
intervention-driven changes would be large enough to detect,
but unfortunately the power of the study was too low to detect
these small differences. This was also compounded by the large
degree of variation in the metrics used given the age range of
the study population and the large rapid changes associated
with puberty. This can be particularly true for changes in height,
body fat distribution, and insulin levels over a 12-month period.
Furthermore, our primary interest was to determine if the
proposed remote-counseling intervention would be feasible in a
pediatric CHD population, which our results support. However,
not including a control non-CHD population has introduced
some limitations to the study interpretation regarding the
presence of CHD and its influence on patient engagement and
measured outcomes. Ideally, a randomized control trial would
prove to be most beneficial and believe our current protocol is
applicable to a larger randomized control study.
Retention is also an important indicator of program feasibility.
A retention rate of 100% (i.e., no drop-outs) and an attrition rate
of 2% (i.e., 2 of 102 clinic visits missed) are atypical for a lifestyle
intervention program of this duration and nature. Dhaliwal et al.
documented a median attrition rate of 37% (range 4–83%) from
23 published pediatric lifestyle interventions (33). Logistical barriers were one of the most commonly cited reasons for dropout.
The Smart Heart Pilot Study reduced the need for families to
travel during the intervention by providing remote counseling
via smartphones. The majority of participants would have been
required to travel ~50 to 200 km to the hospital. Smartphone
counseling removed the burdens of traveling to the hospital,
missed school and work, as well as the costs of public transit,
petrol, and parking. It is also important to note that enrolled
subjects may have been more amenable to lifestyle changes simply
due to their interest in participating in the study, which could lead
to bias in the results.
There is no research evaluating lifestyle interventions for
children with overweight or obesity and CHD using smartphones. This is the first study to explore this novel approach to
implementing a lifestyle intervention in this high risk population. The Smart Heart Pilot Study proved to be cost-effective and
demonstrated a superior participant retention rate compared to
similar pediatric lifestyle interventions not using smartphones
for remote counseling. Preliminary evidence demonstrates
that the Smart Heart Pilot Study had a positive effect on LBM,
BMI-Z, WC, WC-Z, and WHtR-Z, but this may have been
dependent on self-efficacy and the perception of the underlying heart condition. Despite some study limitations, the results
suggest that a larger study would be highly feasible and likely
prove more successful with improvements to the intervention
protocol. Continued research should elucidate whether the
aforementioned enhancements to the delivery of pediatric
obesity lifestyle interventions demonstrate further improved
cardiovascular health outcomes.
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